Effect of cell-penetrating peptide-conjugated estrogen-related receptor ¥â on the development of mouse embryos cultured in vitro

Clinical and Experimental Reproductive Medicine 2014³â 41±Ç 1È£ p.1 ~ p.8

(Yang Ning-Jie) - CHA University Department of Biomedical Science
¼³µ¿¿ø(Seol Dong-Won) - CHA University College of Life Science Department of Biomedical Science
Á¶Á¤Çö(Jo Jung-Hyun) - CHA University College of Life Science Department of Biomedical Science
ÀåÇö¹Ì(Jang Hyun-Mee) - CHA University College of Life Science Department of Biomedical Science
À±¼÷¿µ(Yoon Sook-Young) - CHA University College of Medicine Fertility Center of CHA Gangnam Medical Center
À̵¿·ü(Lee Dong-Ryul) - CHA University College of Medicine Fertility Center of CHA Gangnam Medical Center

Abstract

Objective: Estrogen related receptor ¥â (Esrrb) is a member of the orphan nuclear receptors and may regulate the expression of pluripotency-related genes, such as Oct4 and Nanog. Therefore, in the present study, we have developed a method for delivering exogenous ESRRB recombinant protein into embryos by using cell-penetrating peptide (CPP) conjugation and have analyzed their effect on embryonic development.

Methods: Mouse oocytes and embryos were obtained from superovulated mice. The expression of Oct4 mRNA and the cell number of inner cell mass (ICM) in the in vitro-derived and in vivo-derived blastocysts were first analyzed by real time-reverse transcription-polymerase chain reaction and differential staining. Then 8-cell embryos were cultured in KSOM media with or without 2 ¥ìg/mL CPP-ESRRB protein for 24 to 48 hours, followed by checking their integration into embryos during in vitro culture by Western blot and immunocytochemistry.

Results: Expression of Oct4 and the cell number of ICM were lower in the in vitro-derived blastocysts than in the in vivo-derived ones (p<0.05). In the blastocysts derived from the CPP-ESRRB-treated group, expression of Oct4 was greater than in the non-treated groups (p<0.05). Although no difference in embryonic development was observed between the treated and non-treated groups, the cell number of ICM was greater in the CPP-ESRRB-treated group.

Conclusion: Treatment of CPP-ESRRB during cultivation could increase embryos¡¯ expression of Oct4 and the formation rate of the ICM in the blastocyst. Additionally, an exogenous delivery system of CPP-conjugated protein would be a useful tool for improving embryo culture systems.

Å°¿öµå

Estrogen-related receptor ¥â, Cell-penetrating peptide, Oct4, Mouse embryo, In vitro culture
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå